US equities |
SPCX $167.09 ▲+5.11% NVDA $236.37 ▲+1.03% MU $1,064.60 ▼-0.96% TSLA $378.45 ▲+2.12% MSFT $525.09 ▲+1.46% SNDK $1,709.68 ▼-0.60% INTC $117.47 ▼-1.56% META $743.59 ▲+2.13%
FinancialContent

Articles published by Anteris Technologies Global Corp.

News headline image
Anteris to Present at September Healthcare Investor Conferences
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Announces Results for the Second Quarter of 2026
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Results for the First Quarter of 2026
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Reports 2025 Financial Results and Provides Corporate Update
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR MDT
News headline image
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Results for the Third Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Announces Results for the Second Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR LMAT
News headline image
Anteris Announces Results for the First Quarter of 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris Reports 2024 Financial Results and Provides Corporate Update
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR
News headline image
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
From Anteris Technologies Global Corp.
Via GlobeNewswire
Tickers ASX:AVR AVR